Royal Bank of Canada
UBX

Royal Bank of Canada’s Unity Biotechnology UBX Stock Holding History

Royal Bank of Canada’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-120
Closed – – 7541
2025
Q2 		$0 Hold
120
– – ﹤0.01% 7360
2025
Q1 		$0 Hold
120
– – ﹤0.01% 7245
2024
Q4 		$0 Hold
120
– – ﹤0.01% 7260
2024
Q3 		$0 Sell
120
-271
-69% -$398 ﹤0.01% 7467
2024
Q2 		$0 Buy
391
+250
+177% +$380 ﹤0.01% 7555
2024
Q1 		$0 Sell
141
-320
-69% -$555 ﹤0.01% 7611
2023
Q4 		$1K Sell
461
-1,453
-76% -$2.7K ﹤0.01% 6989
2023
Q3 		$4K Buy
1,914
+1,794
+1,495% +$4.75K ﹤0.01% 6679
2023
Q2 		$0 Sell
120
-128
-52% -$338 ﹤0.01% 7677
2023
Q1 		$0 Sell
248
-210
-46% -$842 ﹤0.01% 7497
2022
Q4 		$1K Buy
458
+292
+176% +$848 ﹤0.01% 7085
2022
Q3 		$0 Buy
166
+27
+19% +$170 ﹤0.01% 7879
2022
Q2 		$1K Sell
139
-1,095
-89% -$9.13K ﹤0.01% 7213
2022
Q1 		$13K Buy
1,234
+1,100
+821% +$12.3K ﹤0.01% 6845
2021
Q4 		$2K Sell
134
-106
-44% -$2.32K ﹤0.01% 7428
2021
Q3 		$7K Sell
240
-654
-73% -$23.1K ﹤0.01% 7067
2021
Q2 		$42K Buy
894
+238
+36% +$11.5K ﹤0.01% 6154
2021
Q1 		$39K Buy
656
+87
+15% +$5.93K ﹤0.01% 6042
2020
Q4 		$30K Buy
569
+345
+154% +$16.6K ﹤0.01% 5884
2020
Q3 		$8K Sell
224
-145
-39% -$9.18K ﹤0.01% 6014
2020
Q2 		$32K Buy
369
+128
+53% +$9.49K ﹤0.01% 5406
2020
Q1 		$15K Sell
241
-60
-20% -$3.78K ﹤0.01% 5678
2019
Q4 		$22K Buy
301
+101
+51% +$7.13K ﹤0.01% 5819
2019
Q3 		$12K Hold
200
– – ﹤0.01% 5719
2019
Q2 		$19K Buy
200
+120
+150% +$10.2K ﹤0.01% 5751
2019
Q1 		$6K Hold
80
– – ﹤0.01% 6219
2018
Q4 		$13K Sell
80
-20
-20% -$2.65K ﹤0.01% 5771
2018
Q3 		$16K Buy
100
+18
+22% +$2.96K ﹤0.01% 5787
2018
Q2 		$12K Buy
+82
New +$12K ﹤0.01% 5770

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Royal Bank of Canada's UBX Position: Q3 2025 in Review

Royal Bank of Canada sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 120 shares.

Royal Bank of Canada first reported a position in UBX in Q2 2018 and held it in 29 quarters. The position peaked at $42K in Q2 2021. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Royal Bank of Canada reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 120 Unity Biotechnology shares in Q3 2025.
  • Royal Bank of Canada first reported a position in Unity Biotechnology in Q2 2018 and held it in 29 quarters.
  • Royal Bank of Canada's Unity Biotechnology position peaked at $42K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.